Testicular cancer: Biology and biomarkers

Virchows Archiv

Volumn 464, Issue 3, 2014, Pages 301-313

  Looijenga, Leendert H J ^a   Stoop, Hans ^a   Biermann, Katharina ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Carcinoma in situ; Diagnostic markers; Follow up; Germ cell tumor; Gonadoblastoma; Precursor lesions

Indexed keywords

MICRORNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXL2; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR SOX9; TUMOR MARKER; UNCLASSIFIED DRUG;

ALLELE; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; CELL LINEAGE; EARLY DIAGNOSIS; EMBRYO DEVELOPMENT; FOLLOW UP; GENE IDENTIFICATION; GERM CELL; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; MOLECULAR BIOLOGY; NON SEMINOMATOUS GERMINOMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SEMINOMA; TESTIS TERATOMA; VIRILIZATION; Y CHROMOSOME; YOLK SAC TUMOR;

ANIMALS; BIOLOGICAL MARKERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS;

EID: 84897078662     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-013-1522-1     Document Type: Review

References (145)

1. Cunningham JJ et al (2012) Lessons from human teratomas to quide development of safe stem cell therapies. Nat Biotechnol 30(9):849-857
2. Horwich A, Shipley J, Huddart R (2006) Testicular germ-cell cancer. Lancet 367(9512):754-765 (Pubitemid 43326294)
3. Van Leeuwen FE et al (1993) Second cancer risk following testicular cancer: a follow-up study of 1,909 patients. J Clin Oncol 11:415-424 (Pubitemid 23071036)
4. Haugnes HS et al (2010) Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. J Clin Oncol 28(30):4649-4657
5. Beyer J et al (2013) Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol 24(4):878-888
6. Westerman BA et al (2011) A genome-wide RNAi screen in mouse embryonic stem cells identifies Mp1 as a key mediator of differentiation. J Exp Med 208(13):2675-2689
7. Spiller CM et al (2012) Endogenous Nodal signalling regulates germ cell potency during mammalian testis development. Development 139(22):4123-4132
8. Oosterhuis JW, Looijenga LH (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5(3):210-222 (Pubitemid 40314952)
9. Woodward PJ et al (2004) Testicular germ cell tumors, in World Health Organization classification of tumours . In: Eble JN et al (eds) Pathology and Genetics of the urinary system and male genital organs. IARC Press, Lyon, pp 217-278
10. Reuter VE (2005) Origins and molecular biology of testicular germ cell tumors. Mod Pathol 18(Suppl 2):S51-S60
11. Ye H, Ulbright TM (2012) Difficult differential diagnoses in testicular pathology. Arch Pathol Lab Med 136(4):435-446
12. Honecker F et al (2006) Germ cell lineage differentiation in nonseminomatous germ cell tumors. J Pathol 208:395-400 (Pubitemid 43210526)
13. Looijenga LHJ (2008) Human testicular (non)seminomatous germ cell tumors: patho-biology and optimal diagnostics. J Pathol 218:146-162
14. Looijenga LH et al (2006) Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res 66(1):290-302 (Pubitemid 43166035)
15. Looijenga LH (2011) Spermatocytic seminoma: toward further understanding of pathogenesis. J Pathol 224(4):431-433
16. Kristensen DG et al (2012) Heterogeneity of chromatin modifications in testicular spermatocytic seminoma point toward an epigenetically unstable phenotype. Cancer Genet 205(9):425-431
17. Lim J et al (2011) OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia. J of Pathol 224(4):473-483
18. Goriely A et al (2009) Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nat Genet 41:1247-1251
19. Bergström R et al (1996) Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 88:727-733 (Pubitemid 26195020)
20. Aschim EL et al (2005) Is there an association between maternal weight and the risk of testicular cancer? An epidemiologic study of Norwegian data with emphasis on World War II. Int J Cancer 116(2):327-330 (Pubitemid 40967273)
21. Stephansson O et al (2011) Perinatal risk factors for childhood testicular germ-cell cancer: a Nordic population-based study. Cancer Epidemiol 35(6):e100-e104
22. Cook MB et al (2009) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer - experiences of the mother. Int J Epidemiol 38(6):1532-1542
23. Skakkebaek NE (2003) Testicular dysgenesis syndrome. Horm Res 60(Suppl 3):49
24. Akre O, Richiardi L (2009) Does a testicular dysgenesis syndrome exist? Hum Reprod 24(9):2053-2060
25. Ramlau-Hansen CH et al (2009) Perinatal markers of estrogen exposure and risk of testicular cancer: follow-up of 1,333,873 Danish males born between 1950 and 2002. Cancer Causes Control 20(9):1587-1592
26. Hsieh MH et al (2012) Caucasian male infants and boys with hypospadias exhibit reduced anogenital distance. Hum Reprod 27(6):1577-1580
27. Zheng Z, Cohn MJ (2011) Developmental basis of sexually dimorphic digit ratios. Proc Natl Acad Sci U S A 108(39):16289-16294
28. Auger J, Eustache F (2011) Second to fourth digit ratios, male genital development and reproductive health: a clinical study among fertile men and testis cancer patients. Int J Androl 34(4 Pt 2):e49-e58
29. Holl K et al (2009) Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: a nested case-referent study. Int J Cancer 124(12):2923-2928
30. Cools M et al (2006) Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 27:468-484 (Pubitemid 44213228)
31. Looijenga LH et al (2007) Tumor risk in disorders of sex development (DSD). Best Pract Res Clin Endocrinol Metab 21(3):480-495 (Pubitemid 47393445)
32. Hersmus R et al (2008) New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD). Mol Cell Endocrinol 291(1-2):1-10
33. Looijenga LH et al (2010) Gonadal tumours and DSD. Best Pract Res Clin Endocrinol Metab 24(2):291-310
34. Pleskacova J et al (2010) Tumor risk in disorders of sex development. Sex Dev 4:259-269
35. Page DC (1987) Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development 101(Suppl):151-155
36. Skakkebæk NE (1972) Possible carcinoma-in-situ of the testis. Lancet: p. 516-517
37. Scully RE (1970) Gonadoblastoma. A review of 74 cases. Cancer 25:1340-1356
38. Hersmus RKN, De Leeuw B, Stoop H, Oosterhuis JW, Wolffenbuttel KP, Drop SLS, Veitia RA, Fellous M, Jaubert F, Looijenga LHJ (2008) FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). J Pathol 215:31-38 (Pubitemid 351619873)
39. Novotny GWet al (2012) MicroRNA expression profiling of carcinoma in situ cells of the testis. Endocr Relat Cancer 19(3):365-379
40. Sonne SB et al (2009) Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res 69(12):5241-5250
41. Jorgensen A et al (2012) Analysis of meiosis regulators in human gonads: a sexually dimorphic spatio-temporal expression pattern suggests involvement of DMRT1 in meiotic entry. Mol Hum Reprod 18(11):523-534
42. Eckert D et al (2008) Expression of BLIMP1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors. BMC Dev Biol 8(1):106
43. Netto GJ et al (2008) Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors. Mod Pathol 21:1337-11344
44. Werman H et al (2010) Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance. J Pathol 221:433-442
45. Kristensen DG et al (2013) Epigenetic features of testicular germ cell tumours in relation to epigenetic characteristics of foetal germ cells. Int J Dev Biol 57(2-3-4):309-317
46. Van Gurp RJLM et al (1994) Human testicular germ cell tumors show biallelic expression of the H19 and IGF2 gene. J Natl Cancer Inst 86:1070-1075
47. Verkerk AJ et al (1997) Unique expression patterns of H19 in human testicular cancers of different etiology. Oncogene 14(1):95-107 (Pubitemid 27042959)
48. Millan JL, Manes T (1988) Seminoma-derived Nagao isozyme is encoded by a germ-cell alkaline phosphatase gene. Proc Natl Acad Sci U S A 1985:3024-3028
49. Roelofs H et al (1999) Heterogeneity in alkaline phosphatase isozyme expression in human testicular germ cell tumors: an enzyme-/immunohistochemical and molecular analysis. J Pathol 189:236-244 (Pubitemid 29448919)
50. Stoop H et al (2011) Diagnosis of testicular carcinoma in situ '(intratubular and microinvasive)' seminoma and embryonal carcinoma using direct enzymatic alkaline phosphatase reactivity on frozen histological sections. Histopathology 58(3):440-446
51. Strohmeyer T et al (1991) Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res 51:1811-1816
52. Rajpert-DeMeyts E, Skakkebæk NE (1994) Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours. Int J Androl 17:85-92 (Pubitemid 24125601)
53. Meyts ER et al (1996) Prolonged expression of the c-kit receptor in germ cells of intersex fetal testes. J Pathol 178(2):166-169
54. Biermann K et al (2007) c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma. J Pathol 213(3):311-318 (Pubitemid 350074021)
55. Biermann K, Stoop H, Looijenga L (2012) c-KIT protein expression does not discriminate neoplastic from non-neoplastic intratubular germ cells. Histopathology 60(6):1017-1019
56. Looijenga LHJ et al (2003) Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ cell tumors. Cancer Res 63:7674-7678 (Pubitemid 37466695)
57. Rapley EA et al (2004) Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer 90:2397-2401 (Pubitemid 38961906)
58. McIntyre A et al (2005) Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res 65(18):8085-8089 (Pubitemid 41330569)
59. McIntyre A et al (2005) Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumors. Neoplasia 7(12):1047-1052 (Pubitemid 44430982)
60. Looijenga LHJ et al (2003) POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63:2244-2250 (Pubitemid 36538633)
61. De Jong JSJ, Gillis AJM, VanGurp RJHLM, Van deGeijn JGM, De Boer M, Hersmus R, Saunders PTK, Anderson RA, Oosterhuis JW, Looijenga LHJ (2008) Differential expression of SOX17 and SOX2 in human normal and malignant germ cells and stem cells has biological and clinical implications. J Pathol 215:21-30 (Pubitemid 351619872)
62. Korkola JE et al (2005) Gene expression-based classification of nonseminomatous male germ cell tumors. Oncogene 24(32):5101-5107 (Pubitemid 41129087)
63. Gopalan A et al (2009) Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas. Mod Pathol 22(8):1066-1074
64. van Casteren NJ et al (2008) Noninvasive detection of testicular carcinoma in situ in semen using OCT3/4. Eur Urol 54:153-158
65. Almstrup K et al (2011) Screening of subfertile men for testicular carcinoma in situ by an automated image analysis-based cytological test of the ejaculate. Int J Androl 34(4 Pt 2):e21-e30, discussion e30-1
66. Stoop H et al (2008) Stem cell factor as a novel diagnostic marker for early malignant germ cells. J Pathol 216:43-54
67. Rosenberg C et al (2000) Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas. Oncogene 19:5858-5862 (Pubitemid 32005366)
68. Lin Y et al (2012) Reciprocal regulation of akt and oct4 promotes the self-renewal and survival of embryonal carcinoma cells. Mol Cell 48(4):627-640
69. La Sala G, Farini D, De Felici M (2010) Rapid estrogen signalling in mouse primordial germ cells. Exp Cell Res 316(10):1716-1727
70. Kimura T et al (2008) AKT signaling promotes derivation of embryonic germ cells from primordial germ cells. Development 135(5):869-879 (Pubitemid 351524141)
71. Kimura T, Nakano T (2011) Induction of pluripotency in primordial germ cells. Histol Histopathol 26(5):643-650
72. Moe-Behrens GH et al (2003) Akt/PTEN signaling mediates estrogen-dependent proliferation of primordial germ cells in vitro. Mol Endocrinol 17(12):2630-2638 (Pubitemid 37542223)
73. Alva JA et al (2011) Phosphatase and tensin homolog regulates the pluripotent state and lineage fate choice in human embryonic stem cells. Stem Cells 29(12):1952-1962
74. Di Vizio D et al (2005) Loss of the tumor suppressor gene PTEN marks the transition fromintratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. Oncogene 10:1882-1894 (Pubitemid 40462790)
75. Teng DH et al (1997) MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57(23):5221-5225 (Pubitemid 27516352)
76. Arnemann J et al (1991) Cloning and sequence analysis of a human Y-chromosome-derived, testicular cDNA, TSPY. Genomics 11(1):108-114
77. Manz E et al (1993) TSPY-related sequences represent a microheterogeneous gene family organized as constitutive elements in DYZ5 tandem repeat units on the human Y chromosome. Genomics 17(3):726-731 (Pubitemid 23282828)
78. Schnieders F et al (1996) Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet 5(11):1801-1807 (Pubitemid 26372417)
79. Hildenbrand R et al (1999) Detection of TSPYprotein in a unilateral microscopic gonadoblastoma of a Turner mosaic patient with a Y-derived marker chromosome. J Pathol 189(4):623-626
80. Kersemaekers AM et al (2005) Identification of germcells at risk for neoplastic transformation in gonadoblastomas: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol 36:512-521
81. Ng SB et al (2008) Gonadoblastoma-associated mixed germ cell tumour in 46, XY complete gonadal dysgenesis (Swyer syndrome): analysis of Y chromosomal genotype and OCT3/4 and TSPY expression profile. Histopathology 52(5):644-646 (Pubitemid 351442663)
82. Oram SW et al (2006) TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer 6:154
83. Vogel T, Schmidtke J (1998) Structure and function of TSPY, the Y-chromosome gene coding for the "testis-specific protein". Cytogenet Cell Genet 80(1-4):209-213 (Pubitemid 28330386)
84. Dechend F et al (2000) TSPY variants in six loci on the human Y chromosome. Cytogenet Cell Genet 91(1-4):67-71 (Pubitemid 32110343)
85. Schubert S et al (2000) Molecular evolution of the murine tspy genes. Cytogenet Cell Genet 91(1-4):239-242 (Pubitemid 32110373)
86. Schubert S et al (2003) Generation and characterization of a transgenic mouse with a functional human TSPY. Biol Reprod 69(3):968-975 (Pubitemid 37064626)
87. Sturgeon CM et al (2008) National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 54(12):e11-e79 (Pubitemid 352777353)
88. von Eyben FE et al (2000) Lactate dehydrogenase isoenzyme 1 is the most important LD isoenzyme in patients with testicular germ cell tumor. Acta Oncol 39(4):509-517
89. Kawakami T et al (2004) XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer. Lancet 363(9402):40-42 (Pubitemid 38076925)
90. Looijenga LH et al (1997) X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status. Am J Pathol 151(2):581-590 (Pubitemid 27330078)
91. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843-854 (Pubitemid 24014542)
92. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6(4):259-269
93. Rosa A, Brivanlou AH (2011) A regulatory circuitry comprised of miR-302 and the transcription factors OCT4 and NR2F2 regulates human embryonic stem cell differentiation. EMBO J 30(2):237-248
94. Voorhoeve PMet al (2006) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124(6):1169-1181
95. Aylon Yet al (2006) A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev 20(19):2687-2700
96. Van Echten-Arends J et al (1995) No recurrent structural abnormalities in germ cell tumors of the adult testis apart from i(12p). Genes Chromosom & Cancer 14:133-144
97. Gillis AJ et al (2007) High-throughput microRNAome analysis in human germ cell tumours. J Pathol 213(3):319-328 (Pubitemid 350074022)
98. Palmer RD et al (2010) Malignant germ cell tumors display commonmicroRNAprofiles resulting in global changes in expression of messenger RNA targets. Cancer Res 70(7):2911-2923
99. McIver SC et al (2012) A Unique combination of male germ cell miRNAs coordinates gonocyte differentiation. PLoS One 7(4):e35553
100. McIver SC et al (2012) miRNA and mammalian male germ cells. Hum Reprod Update 18(1):44-59
101. de Boer CM et al (2012) DICER1 RNase IIIb domain mutations are infrequent in testicular germ cell tumours. BMCResearch Notes 5:569
102. Murray MJ, Coleman N (2012) Testicular cancer: a new generation of biomarkers for malignant germ cell tumours. Nat Rev Urol 9:298-300
103. Belge G et al (2012) Serum levels of microRNAs miR-371-3: a novel class of serumbiomarkers for testicular germ cell tumors? Eur Urol 61(5):1068-1069
104. Rijlaarsdam MA et al (2013) miMsg: a target enrichment algorithm for predicted miR-mRNA interactions based on relative ranking of matched expression data. Bioinformatics 29(13):1638-1646
105. Murray MJ et al (2011) Identification of microRNAs From the miR-371 373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am J Clin Pathol 135(1):119-125
106. Rapley EA et al (2009) A genome-wide association study of testicular germ cell tumor. Nat Genet 41(7):807-810
107. Kanetsky PA et al (2009) Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet 41(7):811-815
108. Turnbull C et al (2010) Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet 42(7):604-607
109. Kanetsky PA et al (2011) A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility. Hum Mol Genet 20(15):3109-3117
110. Kratz CP et al (2011) Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour. J Med Genet 48(7):473-476
111. Kratz CP et al (2011) A stratified genetic risk assessment for testicular cancer. Int J Androl 34(4 Pt 2):e98-e102
112. Ferlin A et al (2012) Variants in KITLG predispose to testicular germ cell cancer independently from spermatogenic function. Endocr Relat Cancer 19(1):101-108
113. Kristiansen W et al (2012) Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population. Hum Reprod 27(5):1525-1535
114. Dalgaard MD et al (2012) A genome-wide association study of men with symptoms of testicular dysgenesis syndrome and its network biology interpretation. J Med Genet 49(1):58-65
115. Horvath A et al (2009) Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors. Cancer Res 69(13):5301-5306
116. Greene MH et al (2010) Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. Endocr Relat Cancer 17(2):R109-R121
117. Schumacher FR et al (2013) Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Hum Mol Genet 22(13):2748-2753
118. Chung CC et al (2013) Meta-analysis identifies four new loci associated with testicular germcell tumor. Nat Genet 45(6):680-685
119. Ruark E et al (2013) Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. Nat Genet 45(6):686-689
120. Basten SG et al (2013) Mutations in LRRC50 predispose zebrafish and humans to seminomas. PLoS Genet 9(4):e1003384
121. Zeron-Medina J et al (2013) A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection. Cell 155(2):410-422
122. Looijenga LH, Van Agthoven T, Biermann K (2013) Development of malignant germ cells - the genvironmental hypothesis. Int J Dev Biol 57(2-3-4):241-253
123. Amatruda JF et al (2002) Zebrafish as a cancer model system. Cancer Cell 1(3):229-231 (Pubitemid 41039146)
124. Neumann JC et al (2011) Mutation in the type IB bone morphogenetic protein receptor Alk6b impairs germ-cell differentiation and causes germ-cell tumors in zebrafish. Proc Natl Acad Sci U S A 108(32):13153-13158
125. Neumann JC et al (2011) Zebrafish models of germ cell tumor. Methods Cell Biol 105:3-24
126. Stevens LC (1970) The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Dev Biol 21:364-382
127. Stevens LC, Varnum DS (1974) The development of teratomas from parthenogenetically activated ovarian mouse eggs. Dev Biol 37:369-380
128. Walt H, Oosterhuis JW, Stevens LC (1993) Experimental testicular germ cell tumorigenesis in mouse strains with and without spontaneous tumours differs fromdevelopment of germcell tumours of the adult human testis. Int J Androl 16:267-271 (Pubitemid 23310291)
129. Kedde M et al (2007) RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 131(7):1273-1286
130. Youngren KK et al (2005) The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature 435(7040):360-364 (Pubitemid 40745546)
131. Ketting RF (2007) A dead end for microRNAs. Cell 131(7):1226-1227
132. Nelson VR et al (2012) Transgenerational epigenetic effects of the Apobec1 cytidine deaminase deficiency on testicular germ cell tumor susceptibility and embryonic viability. Proc Natl Acad Sci U S A 109(41):16414-16415
133. Heaney JD et al (2008) Loss of the transmembrane but not the soluble kit ligand isoform increases testicular germ cell tumor susceptibility in mice. Cancer Res 68(13):5193-5197
134. Runyan C et al (2006) Steel factor controls midline cell death of primordial germ cells and is essential for their normal proliferation and migration. Development 133(24):4861-4869 (Pubitemid 46085052)
135. Wylie C (1999) Germ cells. Cell 96(2):165-174
136. Holm TM et al (2005) Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8(4):275-285 (Pubitemid 41443413)
137. Looijenga LH et al (1998) Genomic imprinting in testicular germ cell tumours. Apmis 106(1):187-197 (Pubitemid 28123355)
138. Lee J et al (2009) Genetic reconstruction of mouse spermatogonial stem cell self-renewal in vitro by Ras-cyclin D2 activation. Cell Stem Cell 5(1):76-86
139. Krentz AD, Kim Shinseog MM, Cook MS, Capel B, Zhu R, Matin A, Sarver AL, Parker KL, Griswold MD, Looijenga LHJ, Bardwell VJ, Zarkower D (2009) The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency. Proc Natl Acad Sci U S A 106(52):22323-22328
140. Matson CK et al (2011)DMRT1 prevents female reprogramming in the postnatal mammalian testis. Nature 476(7358):101-104
141. Matson CK, Zarkower D (2012) Sex and the singular DM domain: insights into sexual regulation, evolution and plasticity. Nat Rev Genet 13(3):163-174
142. Uhlenhaut NH, Treier M (2006) Foxl2 function in ovarian development. Mol Genet Metab 88(3):225-234 (Pubitemid 43963439)
143. Uhlenhaut NH et al (2009) Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 139(6):1130-1142
144. Raymond CS et al (2000) Dmrt1, a gene related to worm and fly sexual regulators, is required for mammalian testis differentiation. Genes Dev 14(20):2587-2595
145. Welsh M et al (2008) Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest 118(4):1479-1490 (Pubitemid 351500441)